Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Magnesium oxide (MgO)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 14 USDMF, 2 CEP/COS, 11 JDMF, 2 KDMF, 4 NDC API, 10 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers, 6 FDA Orange Book, 19 Europe, 5 Canada, 21 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 9 Rochem International Inc, 19 SPI Pharma, 24 DKSH, 1 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Kewpie Corporation, 9 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 1 Avesta Pharma, 34 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 1 Clariant, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 13 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 41 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 52 Thickeners and Stabilizers, 45 Disintegrants & Superdisintegrants, 38 Solubilizers, 37 Taste Masking, 36 Direct Compression, 36 Parenteral, 30 Granulation, 29 Controlled & Modified Release, 26 Topical, 25 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 21 Lubricants & Glidants, 16 Emulsifying Agents, 15 Co-Processed Excipients, 13 Rheology Modifiers, 9 Empty Capsules, 8 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 9 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

12 APIs, 2 FDF Dossiers, 5 EXCIPIENTS

PATENTS & EXCLUSIVITIES

6 US Patents

6 US Patents

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Dead Sea Periclase	Israel	DEAD SEA BROMINE COMPANY LTD. Beer Sheva IL	R1-CEP 2007-111 - Rev 02	Magnesium oxide, heavy	2018-02-28	Valid	Chemical		41
29/11/2025	SCORA SA	France	SCORA Caffiers FR	CEP 2024-141 - Rev 00	Magnesium oxide, light	2025-07-28	Valid	Chemical		40

Magnesium Oxide (MgO)

Magnesium oxide (MgO)

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

14 USDMF

2 CEP/COS

11 JDMF

2 KDMF

4 NDC API

10 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers

6 FDA Orange Book

19 Europe

5 Canada

21 South Africa

12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

2 EUROAPI

9 Rochem International Inc

19 SPI Pharma

24 DKSH

1 Pharm-RX Chemical

8 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

2 Kewpie Corporation

9 Nanjing Well Pharmaceutical

2 Pfanstiehl

7 Kirsch Pharma

4 ACG Worldwide

11 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Ashland

1 Avesta Pharma

34 BASF

1 Bioplus Life Sciences

1 CD Formulation

1 Clariant

11 Corel Pharma Chem

4 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

5 Ideal Cures

5 Ingredion Pharma Solutions

13 Kerry

4 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

18 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

10 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

41 Roquette

13 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

3 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

4 The Dow Chemical Company

2 Ulanqab Kema New Material

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons